Dr Andrea Douglas

Investment Committee member

Dr Andrea Douglas is the Senior Vice President, Organisation Transformation and External Affairs at CSL Limited, located at CSL’s headquarters in Parkville, Australia. Dr Douglas leads CSL’s Organisation Transformation Office, which integrates and drives major organisational design changes that have broad implications to the business across areas of strategy, structure, governance, process and people. Dr Douglas also leads CSL’s government affairs strategy in Australia.

Dr Douglas has held various roles at CSL since 2005, including Vice President, R&D Strategy and External Affairs where she led the global R&D strategy, product portfolio, R&D investment and prioritisation processes. She was also Vice President, Licensing, Head of Global R&D Project Management and Program Director, Influenza.

Before joining CSL Dr Douglas was the CEO of the Gene CRC. She also held a senior research role at WEHI where she studied the molecular genetics of breast cancer.

Dr Douglas has a PhD degree in Forensic Medicine from Monash University.  She also holds a Masters degree in Health Administration and is a Graduate of the Australian Institute of Company Directors. She has been a Director of AusBiotech since 2013 and the Baker Heart and Diabetes Institute since 2016 and joined the BioCurate Board in February 2018.